Skip to main content

Over-the-counter medicine

Tioconazole First approved as Tz-3

Tioconazole (Tz-3) is an over-the-counter medicine with an FDA approval on record since 1983. FDA's NDC Directory lists it from 17 generic labelers, and pharmacies paid $2.41 per gram (Tioconazole-1 6.5% ointment) in the October 7, 2026 NADAC survey.

  • Generic listed
  • Over the counter

Check it at the source: the tioconazole FDA label on DailyMed (effective December 19, 2023, L. Perrigo Company); the NDA 18682 record on Drugs@FDA; every tioconazole label on DailyMed.

Highlights of the record

FDA label of December 19, 2023; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage

treats vaginal yeast infections

Forms and strengths

  • 6.5 g/100g

Ointment.

On the market

Earliest approval on file
February 18, 1983 Tz-3, Pfizer; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
1 first November 21, 2001; 1 with a marketed status in Drugs@FDA
Labelers listed (NDC)
17 of which 17 under generic applications, 0 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
$2.41 per gram Tioconazole-1 6.5% ointment
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
1,541 through July 30, 2026

What is tioconazole used for?

From the label: indications and usage

treats vaginal yeast infections

FDA pharmacologic class: Azole Antifungal.

Source: FDA drug label (good sense tioconazole 1), L. Perrigo Company, effective December 19, 2023 (SPL set d39ac447-6e1d-4b77-90c1-a9a653661f42), via openFDA; the full label on DailyMed

Is there a generic for tioconazole (Tz-3)?

The FDA approved the first generic tioconazole on November 21, 2001. 1 generic application is approved; 1 of it carries a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.

FDA's NDC Directory lists tioconazole from 17 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

  • 1983 earliest approval on file
  • 2001 first generic approved

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for tioconazole (Tz-3)?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $2.41 per gram (Tioconazole-1 6.5% ointment), up 3% from $2.34 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

  • Ft tioconazole-1 6.5% ointment (generic)
$2.43
$2.23
May 2024October 2026
NADAC per unit, October 7, 2026
Strength and formBrand or genericPharmacy cost30 tablets, or one pen or vial12-month change
Ft tioconazole-1 6.5% ointmentGeneric$2.41 per gramn/a+3%
Tioconazole 1 6.5% ointmentGeneric$2.41 per gramn/a+3%
Tioconazole-1 6.5% ointmentGeneric$2.41 per gramn/a+3%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What do FAERS reports show for tioconazole?

The FDA Adverse Event Reporting System holds 1,541 reports that list tioconazole among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 19 are coded as a death and 42 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Vulvovaginal Burning Sensation526
  • Drug Ineffective (a use or a product term, not a reaction)441
  • Vulvovaginal Swelling295
  • Vulvovaginal Pain229
  • Condition Aggravated (a use or a product term, not a reaction)226
  • Vulvovaginal Pruritus197
  • Vulvovaginal Discomfort161
  • Vaginal Discharge (named in the label)59

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other azole antifungals
the pharmacologic class, with prices and generics
Tioconazole side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other